Strategic leadership Recent leadership change with Doug Godshall as Chairman and CEO positions Galvanize for accelerated growth and potential strategic partnerships. Leverage executive credibility to pursue collaborations with large electrophysiology players and alternative treatment centers.

Financing momentum New $100M Series C financing signals strong investor confidence and readiness for expansion. Target strategic customers and partners who can scale with new funding, including hospitals and clinics exploring non-thermal ablation options.

Product readiness CENTAURI PEF system offers non-thermal cardiac ablation compatible with select catheters and mapping systems, though not US-ready for sale. Explore international deployments, integration with partner platforms, and device-agnostic collaborations to broaden reach.

Asset divestiture history Past divestiture of electrophysiology assets to CardioFocus indicates transactional flexibility and ongoing interest in strategic asset realignment. Approach potential acquisition or collaboration discussions with a focus on complementary portfolios.

Market position Small team scale with high-potential technology sits between niche innovation and major players. Position as a value-add supplier of PEF-based solutions to large medical device ecosystems and established EP manufacturers seeking non-thermal options.